As part of the expanded partnership, Waters and BTI will identify and visualize molecules within glycomics and metabolomics data to improve the safety, accuracy, and speed of biologics manufacturing, according to the two firms. The collaboration will focus on molecules such as N- and O-glycans and metabolites that affect the function of therapeutics.

Waters plans to contribute its scientific expertise and instruments such as its Synapt series mass spectrometry system and its BioAccord liquid chromatography-mass spectrometry (LC-MS) System.

Waters launches Arc Premier liquid chromatography
Lab equipment supplier Waters has unveiled the Arc Premier system, a liquid chromatography system aimed at increasing precision and certainty in chromatography...

Waters debuts mass spectrometer with MRT technology
Waters has introduced its next-generation Select Series multireflecting time-of-flight (MRT) mass spectrometer. The new system is designed to provide...

Waters launches SARS-CoV-2 LC-MS research kit
Lab equipment supplier Waters has debuted a new SARS-CoV-2 liquid chromatography–mass spectrometry (LC–MS) Kit for research use only. The kit uses an...

Sciex, Waters collaborate to offer fully integrated LC-MS systems
Sciex and Waters have inked a deal to provide integrated liquid chromatography and mass spectrometry (LC-MC) systems.

Waters reports 30% sales increase in Q1
Lab equipment supplier Waters reported significant sales growth during the first quarter of 2021.